Related Experiment Video
Updated: May 4, 2026

Metabolic Pathway Confirmation and Discovery Through 13C-labeling of Proteinogenic Amino Acids
Published on: January 26, 2012
Discovery of a metabolic alternative to the classical mevalonate pathway
Nikki Dellas1, Suzanne T Thomas, Gerard Manning
1Howard Hughes Medical Institute, Salk Institute for Biological Studies, La Jolla, United States.
Abstract:
Eukarya, Archaea, and some Bacteria encode all or part of the essential mevalonate (MVA) metabolic pathway clinically modulated using statins. Curiously, two components of the MVA pathway are often absent from archaeal genomes. The search for these missing elements led to the discovery of isopentenyl phosphate kinase (IPK), one of two activities necessary to furnish the universal five-carbon isoprenoid building block, isopentenyl diphosphate (IPP). Unexpectedly, we now report functional IPKs also exist in Bacteria and Eukarya. Furthermore, amongst a subset of species within the bacterial phylum Chloroflexi, we identified a new enzyme catalyzing the missing decarboxylative step of the putative alternative MVA pathway. These results demonstrate, for the first time, a functioning alternative MVA pathway. Key to this pathway is the catalytic actions of a newly uncovered enzyme, mevalonate phosphate decarboxylase (MPD) and IPK. Together, these two discoveries suggest that unforeseen variation in isoprenoid metabolism may be widespread in nature. DOI: http://dx.doi.org/10.7554/eLife.00672.001.
Insights
Researchers discovered a new alternative mevalonate (MVA) pathway in bacteria, involving the enzymes isopentenyl phosphate kinase (IPK) and mevalonate phosphate decarboxylase (MPD). This finding reveals significant variation in essential isoprenoid metabolism across different life forms.
Area of Science:
- Biochemistry
- Metabolic Pathways
- Microbiology
Background:
- The mevalonate (MVA) pathway is essential for producing isoprenoids in Eukarya, Archaea, and some Bacteria.
- Statins are clinically used to modulate the MVA pathway.
- Two MVA pathway components are frequently absent in archaeal genomes, prompting a search for missing elements.
Purpose of the Study:
- To identify missing components of the MVA pathway in archaeal genomes.
- To investigate the presence and function of isopentenyl phosphate kinase (IPK) in Bacteria and Eukarya.
- To uncover alternative MVA pathways and their key enzymes.
Main Methods:
- Genomic analysis to identify missing MVA pathway enzymes.
- Biochemical assays to characterize enzyme activity.
- Comparative genomics to understand evolutionary distribution of metabolic pathways.
Main Results:
- Discovery of isopentenyl phosphate kinase (IPK) activity in Bacteria and Eukarya, not just Archaea.
- Identification of a novel enzyme, mevalonate phosphate decarboxylase (MPD), in Chloroflexi bacteria.
- Demonstration of a functioning alternative MVA pathway utilizing IPK and MPD.
Conclusions:
- A functional alternative MVA pathway exists, involving IPK and the newly identified MPD.
- Isoprenoid metabolism exhibits greater variation than previously understood.
- These findings have implications for understanding microbial metabolism and evolution.
More Related Videos
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Lipid Catabolism
Biosynthesis of Lipids
Amino Acid Biosynthetic Pathways
Metabolism of Chemolithotrophs
Inborn Errors of Metabolism

